Early Phase Research Site Strategy Summit

On-Demand Content | Virtual Event

Dear Colleague,

Brought to you by the organizers of the leading Billing compliance event in the market, this event provides sites with the insights into performing Phase I trials effectively and maintaining compliance. Hear from phase I leaders as they share their best practices. Learn and network amongst other sites, sponsors, researchers and experts with the highest standards of integrity, respect and professionalism. By attending this event, you will learn what you need to start a phase I program or how you can advance the program you currently have. Our mission is to reinforce your proficiency in building an efficient business model to conduct phase I clinical trials.

Sincerely,

Kelly Willenberg

Kelly Willenberg
CEO
KELLY WILLENBERG & ASSOCIATES

Bryon Main
COO
MOMENTUM EVENTS

The Compliance Certification Board (CCB)® has approved this event for up to 6.9  live CCB CEUs based on a 50-minute hour. Continuing Education Units are awarded based on individual attendance records. Granting of prior approval in no way constitutes endorsement by CCB of this event content or of the event sponsor.

Conference Chairperson

Kelly Willenberg
Kelly Willenberg
CEO

KELLY WILLENBERG & ASSOCIATES

Keynote Speaker

Stephanie L. Graff, MD, FACP
Director of Breast Oncology, Lifespan Cancer Institute, Assistant Professor of Medicine

BROWN UNIVERSITY

Featured Speakers

Cindy Dunn
Cindy Dunn
Independent Contractor

KELLY WILLENBERG & ASSOCIATES

Angela Ebel
Vice President Research Operations

MARY CROWLEY CANCER RESEARCH

Victoria Flores, MBA, ACRP-CP
Victoria Flores, MBA, ACRP-CP
Medicare Coverage Specialist Clinical Research

BAYLOR SCOTT & WHITE HEALTH

Jennifer Kellen
Senior Director, Investigator Grants

EXELIXIS

Teresa Knoop
MSN, RN

AOCN

Jan Kueber, MBA, BSN, OCN
Nurse Manager, Translational Oncology

PRISMA HEALTH

Darshan Kulkarni, Pharm.D, MS, Esq
Regulatory & Compliance Attorney

THE KULKARNI LAW FIRM

Dawn Pittinger
Dawn Pittinger

MOFFITT CANCER CENTER

Wendy Portier
Wendy Portier
Independent Contractor

KELLY WILLENBERG & ASSOCIATES

Reasons to Purchase

  • Better understand and overcome challenges to performing early phase clinical studies
  • Enhance your patient recruitment initiatives for your early phase studies
  • Prioritize the tools and analytics needed to ensure success in Phase 1 and Phase 2 studies
  • Identify and implement effective collaboration techniques with all trial stakeholders

Who Should Purchase

This event is designed for Academic Research Institutions, Hospitals, Clinics and CRO’s that are involved in clinical research in Phase 1 & Phase 2 Executives with the following titles should attend:
  • Research Operations
  • Clinical Trial Operations
  • Research Compliance
  • Contracting & Budgeting
  • Financial Planning
  • Patient Recruitment
  • Research Billing